Himadri Special Q2 FY27 Earnings Call — Analysis (NSE: HSCL)

Himadri Speciality Chemical reported 58% YoY consolidated revenue growth and reaffirmed its FY28 target of ₹1,100+ Cr PAT, supported by multiple advanced battery materials and specialty chemical commissioning milestones across FY27–FY28.

· Analysis by Alpha Inflection

Result quality: watch — Margin pressure. Management sentiment: optimistic.

The take

Q2FY27 Consolidated Revenue from Operations ₹1,691 Cr ( +57.89% YoY ) . Guidance cut — FY?? mining revenue ~₹500 Cr . New story: Innovation-led product upscaling .

Results

Consolidated Q2 FY27 revenue rose 57.9% YoY to ₹1,691 Cr, EBITDA grew 27% YoY to ₹303 Cr, and PAT increased 31% YoY to ₹231 Cr, with EBITDA/MT at ~₹21,000.

Financial highlights

Himadri Special Q2 FY27 reported figures
MetricValueChangeBasis
Consolidated Revenue from Operations₹1,691 Cr+57.89%yoy · Q2FY27 · vs ₹1,071 Cr in Q2FY26
Consolidated EBITDA₹303 Cr+27%yoy · Q2FY27 · vs Q2FY26
Consolidated PAT₹231 Cr+31%yoy · Q2FY27 · vs Q2FY26
Consolidated Revenue from Operations₹3,123 Crnone · H1FY27 · H1FY27 cumulative
Consolidated EBITDA₹616 Crnone · H1FY27 · H1FY27 cumulative
Consolidated PAT₹460 Crnone · H1FY27 · H1FY27 cumulative
Standalone Revenue from Operations₹1,543 Cr+44.2%yoy · Q2FY27 · vs ₹1,070 Cr in Q2FY26
Standalone EBITDA₹308 Cr+26.7%yoy · Q2FY27 · vs ₹243 Cr in Q2FY26
Standalone PAT₹240 Cr+28.3%yoy · Q2FY27 · vs ₹187 Cr in Q2FY26
Standalone Revenue from Operations₹2,817 Crnone · H1FY27 · H1FY27 cumulative
Standalone EBITDA₹610 Cr+27.9%yoy · H1FY27 · vs ₹477 Cr in H1FY26
Standalone PAT₹463 Cr+25.5%yoy · H1FY27 · vs ₹369 Cr in H1FY26

Guidance

Reaffirmed guidance of ₹1,100+ Cr PAT by FY28, funded via internal accruals with ₹800–900 Cr capex planned for FY27.

What management committed to

Key themes

Battery materials scale-up and specialty expansion

How the narrative shifted

Operational commentary

Analyst Q&A

View source

Research and educational content only. Not investment advice.